I have been under the expectation that we were supposed to be transacting the Dx division this quarter. I have also been under the expectation that we will fail to meet the before mentioned expectation. I missed when this got pushed out to Q1 '16, but looks like I was right. Too exhausting trying to keep up with all the constantly changing timelines and strategies.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links